Trustees of Columbia University in the City of New York’s Disc Medicine IRON Stock Holding History

Trustees of Columbia University in the City of New York’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-78,682	Closed	-$3.7M	–	16
2023 Q3	$3.7M	Sell	78,682 -31,806	-29%	-$1.59M	6.8%	3
2023 Q2	$4.91M	Hold	110,488	–	–	7.19%	3
2023 Q1	$2.34M	Hold	110,488	–	–	4.19%	4
2022 Q4	$2.2M	Buy	+110,488	New	+$5.5M	4.53%	3

Other funds holding IRON

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Trustees of Columbia University in the City of New York's IRON Position: Q4 2023 in Review

Trustees of Columbia University in the City of New York sold out of Disc Medicine (IRON) in Q4 2023, closing a stake of 78,682 shares — an estimated $3.7M sold.

Trustees of Columbia University in the City of New York first reported a position in IRON in Q4 2022 and held it in 4 quarters. The position peaked at $4.91M in Q2 2023. 112 funds tracked by Wall St. Rank hold IRON as of Q4 2023.

Trustees of Columbia University in the City of New York reported no remaining Disc Medicine position as of Q4 2023 after selling out during the quarter.
Trustees of Columbia University in the City of New York sold 78,682 Disc Medicine shares in Q4 2023, an estimated $3.7M.
Trustees of Columbia University in the City of New York first reported a position in Disc Medicine in Q4 2022 and held it in 4 quarters.
Trustees of Columbia University in the City of New York's Disc Medicine position peaked at $4.91M in Q2 2023.
112 funds tracked by Wall St. Rank held Disc Medicine as of Q4 2023.

Based on Trustees of Columbia University in the City of New York's 13F filing for Q4 2023, filed 13 Feb 2024.